Skip to content

Dimer Instruments

2 viewers · 30d

Total raised

$11.0M

1 filing since 2024 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $11.0M
ROUNDS
1
INVESTORS
1
FOUNDED
2023
HQ
Santa Barbara, CA
SECTOR
Hardware
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Dimer Instruments is a Santa Barbara, California company building analytical instrumentation for the biopharmaceutical industry. Founded in 2023 by Dr. Stephen Minne and Dr. Michael Larkin, both veterans of light-scattering instrument maker Wyatt Technology, it applies multi-angle and dynamic light scattering (MALS and DLS) and biophysical characterization to drug discovery, formulation, and manufacturing. Its instruments measure protein stability, molecular binding interactions, and protein expression, including process analytical technology (PAT) applications for real-time monitoring during manufacturing.

What sets it apart

Founded by light-scattering instrumentation veterans, the company targets real-time, in-process biophysical measurement (PAT) rather than offline benchtop-only analysis, aiming to move protein characterization onto the manufacturing line.

Funding history

1 round
EquityApr 25, 2024 · $1.0M min
Form D/A
+$11.0M$11.0M total

Latest SEC filings

via EDGAR · CIK 0002004020
Form D/A · Apr 25, 2024View on EDGAR

Products

1 tracked

Biophysical characterization instruments

Scientific and analytical instrumentation

A line of light-scattering and biophysical analysis instruments for biopharma R&D and manufacturing, measuring protein conformational and colloidal stability, binding affinity, and expression levels, with process analytical technology applications for real-time quality monitoring.

  • Multi-angle light scattering (MALS) and dynamic light scattering (DLS) measurement
  • Conformational and colloidal protein stability in a single experiment
  • Binding affinity measurement in solution with low sample consumption
  • Plate-based screening of compound libraries without immobilization